Skip to main content

Post categories

  • Home
  • Contact Us
  • Login
  • Register
Home
  • INDUSTRY UPDATES
    • Packaging News
    • Innovations
    • Packaging Offers
    • Press Releases
    • Events
    • resources
  • BLOG
  • OUR PRODUCTS
    • Big Book of Packaging
  • OUR PARTNERS
    • Bernhardt
    • EMA
    • Haemotronic
    • Linhardt
    • Ypsomed
    • Plas-Tech Engineering
    • Roechling
    • Sanok Rubber
    • Schreiner
    • Polycine
    • Yukon Medical
    • Bonini
  • SERVICES
    • CONSULTING
    • DESIGN SERVICES

Breadcrumb

  1. Home
  2. Aptar Pharma Extends its Child-Resistant Nasal Pump Manufacturing Capabilities in North America

Aptar Pharma Extends its Child-Resistant Nasal Pump Manufacturing Capabilities in North America

Profile picture for user radhika.rewri011
By radhika.rewri011 on Thu, 10/12/2017 - 10:16

Aptar Pharma, a manufacturer of drug delivery systems for nasal applications worldwide, announced the installation of manufacturing capacity for its Child-Resistant and Senior-Friendly Classic Nasal Pump in their Congers, NY site. Effective April 2017, a new assembly machine for Aptar Pharma’s Child-Resistant Feature for nasal sprays was transferred from Aptar Pharma’s plant in Southern Germany to Congers, NY. This represents an important step in Aptar Pharma’s history, bringing its manufacturing capacity closer to the target market for which this pump has been successfully established. Aptar Pharma’s Child-Resistant technology platform was developed primarily for the U.S. market when, in 2012, the U.S. Consumer Product Safety Commission (CPSC) issued a rule requiring Child-Resistant packaging for any over-the-counter or drug product containing the equivalent of 0.08 milligrams or more of imidazoline (16 CFR Part 1700.14), a formulation widely used in nasal decongestant topical sprays. Less than two years after the rule’s announcement, Aptar Pharma introduced its newly-engineered Child-Resistant/Senior-Friendly nasal spray pump to the U.S. market, which successfully matched the CPSC requirements. This feat once more underscored Aptar Pharma’s worldwide reputation as an innovative leader and trusted partner in the pharmaceutical industry.

http://news.aptar.com/solutions/aptar-pharma-extends-its-child-resistant-nasal-…

Follow Us

  • linkedin
  • facebook-f
  • twitter

Explore

  • Home
  • Contact Us
  • Login
  • Register

Company

  • Archive
  • Blog
  • Events
  • Packaging News
Coffee Pods and Tea Bags Can Now Go in The Organic Waste Bin
31 Jan, 2023
Berry, Coca-Cola Collaborate to implement Tethered caps in EU markets
30 Jan, 2023
ProAmpac Expands Recyclable Quad-Seal Packaging Portfolio
30 Jan, 2023

Footer menu

  • Privacy
  • Terms and conditions
Home
  • INDUSTRY UPDATES
    • Packaging News
    • Innovations
    • Packaging Offers
    • Press Releases
    • Events
    • resources
  • BLOG
  • OUR PRODUCTS
    • Big Book of Packaging
  • OUR PARTNERS
    • Bernhardt
    • EMA
    • Haemotronic
    • Linhardt
    • Ypsomed
    • Plas-Tech Engineering
    • Roechling
    • Sanok Rubber
    • Schreiner
    • Polycine
    • Yukon Medical
    • Bonini
  • SERVICES
    • CONSULTING
    • DESIGN SERVICES
Clear keys input element